Epigenetic regulation of pancreas development and function

Seminars in Cell and Developmental Biology

Volumn 23, Issue 6, 2012, Pages 693-700

  Avrahami, Dana ^a   Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DNA methylation; Epigenenetics; Histone marks; Pancreas development

Indexed keywords

DNA; HISTONE; TRANSCRIPTION FACTOR;

CELL FATE; CELL PROLIFERATION; DNA METHYLATION; EPIGENETICS; GENE MUTATION; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; NONHUMAN; ORGANOGENESIS; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PHENOTYPE; REVIEW; TRANSCRIPTION REGULATION;

MUS;

EID: 84865175215     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.06.002     Document Type: Review

References (72)

1. Gittes G.K. Developmental biology of the pancreas: a comprehensive review. Developmental Biology 2009, 326:4-35.
2. Pan F.C., Wright C. Pancreas organogenesis: from bud to plexus to gland. Developmental Dynamics 2011, 240:530-565.
3. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
4. Xu C.R., Cole P.A., Meyers D.J., Kormish J., Dent S., Zaret K.S. Chromatin prepattern and histone modifiers in a fate choice for liver and pancreas. Science 2011, 332:963-966.
5. Collombat P., Hecksher-Sorensen J., Krull J., Berger J., Riedel D., Herrera P.L., et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. Journal of Clinical Investigation 2007, 117:961-970.
6. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464:1149-1154.
7. Sussel L., Kalamaras J., Hartigan-O'Connor D.J., Meneses J.J., Pedersen R.A., Rubenstein J.L., et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998, 125:2213-2221.
8. Hervouet E., Vallette F.M., Cartron P.F. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 2009, 4:487-499.
9. Papizan J.B., Singer R.A., Tschen S.I., Dhawan S., Friel J.M., Hipkens S.B., Magnuson M.A., Bhushan A., Sussel L. Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming. Genes and Development 2011, 25:2291-2305.
10. Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
11. Georgia S., Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. Journal of Clinical Investigation 2004, 114:963-968.
12. Teta M., Rankin M.M., Long S.Y., Stein G.M., Kushner J.A. Growth and regeneration of adult Beta cells does not involve specialized progenitors. Developmental Cell 2007, 12:817-826.
13. Dhawan S., Georgia S., Tschen S.I., Fan G., Bhushan A. Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx. Developmental Cell 2011, 20:419-429.
14. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends in Biochemical Sciences 2006, 31:89-97.
15. Collombat P., Mansouri A., Hecksher-Sorensen J., Serup P., Krull J., Gradwohl G., et al. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes and Development 2003, 17:2591-2603.
16. Sosa-Pineda B., Chowdhury K., Torres M., Oliver G., Gruss P. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997, 386:399-402.
17. Colombo E., Collombat P., Colasante G., Bianchi M., Long J., Mansouri A., et al. Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation. Journal of Neuroscience 2007, 27:4786-4798.
18. Collombat P., Xu X.B., Ravassard P., Sosa-Pineda B., Dussaud S., Billestrup N., et al. The Ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138:449-462.
19. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127:2317-2322.
20. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genetics 2001, 27:31-39.
21. Collombat P., Hecksher-Sorensen J., Broccoli V., Krull J., Ponte I., Mundiger T., et al. The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development 2005, 132:2969-2980.
22. Bird A. DNA methylation patterns and epigenetic memory. Genes and Development 2002, 16:6-21.
23. Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M., Schuchlautz H., et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007, 449:933-937.
24. Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., et al. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes and Development 2007, 21:3369-3380.
25. Bouwens L., Rooman I. Regulation of pancreatic beta-cell mass. Physiological Reviews 2005, 85:1255-1270.
26. Zhong L., Georgia S., Tschen S.I., Nakayama K., Bhushan A. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. Journal of Clinical Investigation 2007, 117:2869-2876.
27. Meier J.J., Butler A.E., Saisho Y., Monchamp T., Galasso R., Bhushan A., et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008, 57:1584-1594.
28. Teta M., Long S.Y., Wartschow L.M., Rankin M.M., Kushner J.A. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005, 54:2557-2567.
29. Tschen S.I., Dhawan S., Gurlo T., Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009, 58:1312-1320.
30. Nielsen G.P., Stemmer-Rachamimov A.O., Ino Y., Moller M.B., Rosenberg A.E., Louis D.N. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. American Journal of Pathology 1999, 155:1879-1884.
31. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., et al. Ink4a/Arf expression is a biomarker of aging. Journal of Clinical Investigation 2004, 114:1299-1307.
32. van der Lugt N.M., Domen J., Linders K., van Roon M., Robanus-Maandag E., te Riele H., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes and Development 1994, 8:757-769.
33. Krishnamurthy J., Ramsey M.R., Ligon K.L., Torrice C., Koh A., Bonner-Weir S., et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443:453-457.
34. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
35. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
36. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
37. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
38. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004, 431:873-878.
39. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes and Development 2007, 21:525-530.
40. Kotake Y., Cao R., Viatour P., Sage J., Zhang Y., Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes and Development 2007, 21:49-54.
41. Chen H., Gu X., Su I.H., Bottino R., Contreras J.L., Tarakhovsky A., et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes and Development 2009, 23:975-985.
42. Collombat P., Hecksher-Sorensen J., Serup P., Mansouri A. Specifying pancreatic endocrine cell fates. Mechanisms of Development 2006, 123:501-512.
43. Gao N., LeLay J., Vatamaniuk M.Z., Rieck S., Friedman J.R., Kaestner K.H. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes and Development 2008, 22:3435-3448.
44. Jonsson J., Carlsson L., Edlund T., Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371:606-609.
45. Offield M.F., Jetton T.L., Labosky P.A., Ray M., Stein R.W., Magnuson M.A., et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122:983-995.
46. Gradwohl G., Dierich A., LeMeur M., Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1607-1611.
47. Haumaitre C., Lenoir O., Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Molecular and Cellular Biology 2008, 28:6373-6383.
48. Gu G., Dubauskaite J., Melton D.A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
49. Chang S., Young B.D., Li S., Qi X., Richardson J.A., Olson E.N. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 2006, 126:321-334.
50. Lagger G., O'Carroll D., Rembold M., Khier H., Tischler J., Weitzer G., et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO Journal 2002, 21:2672-2681.
51. Lenoir O., Flosseau K., Ma F.X., Blondeau B., Mai A., Bassel-Duby R., Ravassard P., Olson E.N., Haumaitre C., Scharfmann R. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9. Diabetes 2011, 60:2861-2871.
52. McKinsey T.A., Zhang C.L., Olson E.N. Control of muscle development by dueling HATs and HDACs. Current Opinion in Genetics and Development 2001, 11:497-504.
53. Montgomery R.L., Davis C.A., Potthoff M.J., Haberland M., Fielitz J., Qi X., et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes and Development 2007, 21:1790-1802.
54. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
55. Chang S., McKinsey T.A., Zhang C.L., Richardson J.A., Hill J.A., Olson E.N. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Molecular and Cellular Biology 2004, 24:8467-8476.
56. Nebbioso A., Manzo F., Miceli M., Conte M., Manente L., Baldi A., et al. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Reports 2009, 10:776-782.
57. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 2006, 24:1392-1401.
58. Furth M.E., Atala A. Stem cell sources to treat diabetes. Journal of Cellular Biochemistry 2009, 106:507-511.
59. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology 2008, 26:443-452.
60. Bhandare R., Schug J., Le Lay J., Fox A., Smirnova O., Liu C., et al. Genome-wide analysis of histone modifications in human pancreatic islets. Genome Research 2010, 20:428-433.
61. Stitzel M.L., Sethupathy P., Pearson D.S., Chines P.S., Song L., Erdos M.R., et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metabolism 2010, 12:443-455.
62. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
63. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
64. van Arensbergen J., Garcia-Hurtado J., Moran I., Maestro M.A., Xu X., Van de Casteele M., et al. Derepression of polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Research 2010, 20:722-732.
65. Dorrell C., Schug J., Lin C.F., Canaday P.S., Fox A.J., Smirnova O., et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 2011, 54:2832-2844.
66. Artner I., Le Lay J., Hang Y., Elghazi L., Schisler J.C., Henderson E., et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 2006, 55:297-304.
67. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nature Reviews Genetics 2008, 9:15-26.
68. Wallrath L.L., Lu Q., Granok H., Elgin S.C. Architectural variations of inducible eukaryotic promoters: preset and remodeling chromatin structures. Bioessays 1994, 16:165-170.
69. Giresi P.G., Kim J., McDaniell R.M., Iyer V.R., Lieb J.D. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Research 2007, 17:877-885.
70. Nagy P.L., Cleary M.L., Brown P.O., Lieb J.D. Genomewide demarcation of RNA polymerase II transcription units revealed by physical fractionation of chromatin. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6364-6369.
71. Gaulton K.J., Nammo T., Pasquali L., Simon J.M., Giresi P.G., Fogarty M.P., et al. A map of open chromatin in human pancreatic islets. Nature Genetics 2010, 42:255-259.
72. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349.